Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences

New drugs and shorter treatments for drug-resistant tuberculosis (DR-TB) have become available in recent years and active pharmacovigilance (PV) is recommended by the World Health Organization (WHO) at least during the early phases of implementation, with active drug safety monitoring and management...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiemersma, Edine, van den Hof, Susan, Dravniece, Gunta, Wares, Fraser, Molla, Yohannes, Permata, Yusie, Lukitosari, Endang, Quelapio, Mamel, Aung, Si Thu, Aung, Khay Mar, Thuy, Hoang Thanh, Hoa, Vu Dinh, Sulaimanova, Merkinai, Sagyndikova, Saadat, Makhmudova, Mavluda, Soliev, Alijon, Kimerling, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Health and Politics Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488907/
https://www.ncbi.nlm.nih.gov/pubmed/31604816
http://dx.doi.org/10.1183/16000617.0115-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488907/
https://www.ncbi.nlm.nih.gov/pubmed/31604816
http://dx.doi.org/10.1183/16000617.0115-2018

Ejemplares similares